Flow Pharma, Inc. — Form D/A

Flow Pharma, Inc. of WARRENSVILLE HEIGHTS, OH, a company, filed a Form D amendment with the SEC on 2024-08-08. The offering totals $40.0M, of which $225K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Tikoes Martin BlankenbergDirectorWarrensville Heights, OH
Babatunde Martin OtulanaDirectorWarrensville Heights, OH
Reid Martin RubsamenDirectorWarrensville Heights, OH
Pamela Martin SteeleDirectorWarrensville Heights, OH
Anthony Martin TufaroDirectorWarrensville Heights, OH
Reid Martin RubsamenExecutive OfficerWarrensville Heights, OH
Gil Martin Van BokkelenExecutive OfficerWarrensville Heights, OH
Thomas Martin BarnishExecutive OfficerWarrensville Heights, OH
Stephen Martin FarrDirectorWarrensville Heights, OH
Charles Vincent HerstExecutive OfficerWarrensville Heights, OH
Tom Martin BradyExecutive OfficerWarrensville Heights, OH
Pamela Vincent SteeleDirectorWarrensville Heights, OH
Babatunde Vincent OtulanaDirectorWarrensville Heights, OH
Lester J LloydDirectorOrinda, CA
Lester J LloydExecutive OfficerOrinda, CA
Lester John LloydDirectorOrinda, CA
Lester John LloydExecutive OfficerOrinda, CA
Reid Michael RubsamenDirectorAlamo, CA
Reid Michael RubsamenExecutive OfficerAlamo, CA
Thomas John BradyExecutive OfficerSierra Madre, CA
Reid M RubsamenDirectorAlamo, CA
Reid M RubsamenExecutive OfficerAlamo, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2024-08-01D$40.0M$50K
2022-11-02D$10.5M$180K
2018-02-28D$2.3M
2018-02-28D$1.1M

More